Oxford's HIV vaccine starts Phase 1 clinical trials in the UK

A novel HIV vaccine, developed at the University of Oxford in the wake of Covid-19 vaccine success, is to be trialled on humans. The goal of the trial, ...


View article...


Top stories of the last 30 days